Divi's Laboratories Limited has reported Consolidated financial results for the period ended June 30, 2024.
Financial Results (Q1 FY2025) - QoQ Comparison
The company has reported total income of Rs. 2197 crores during the period ended June 30, 2024 as compared to Rs. 2382 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs. 430 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 538 crores for the period ended March 31, 2024.
The company has reported EPS of Rs. 16.20 for the period ended June 30, 2024 as compared to Rs. 20.25 for the period ended March 31, 2024.
| Total Income | ₹2197 crs | ₹2382 crs |  -7.77% | | Net Profit | ₹430 crs | ₹538 crs | -20.07% | | EPS | ₹16.20 | ₹20.25 | -20.00% |
Financial Results (Q1 FY2025) - YoY Comparison
The company has reported total income of Rs.2197 crores during the period ended June 30, 2024 as compared to Rs.1859 crores during the period ended June 30, 2023.
The company has posted net profit / (loss) of Rs.430 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.356 crores for the period ended June 30, 2023.
The company has reported EPS of Rs.16.20 for the period ended June 30, 2024 as compared to Rs.13.41 for the period ended June 30, 2023.
| Total Income | ₹2197 crs | ₹1859 crs |  18.18% | | Net Profit | ₹430 crs | ₹356 crs | 20.79% | | EPS | ₹16.20 | ₹13.41 | 20.81% |
Shares of Divi's Laboratories Limited was last trading in BSE at Rs. 4990.35 as compared to the previous close of Rs. 4921.60. The total number of shares traded during the day was 23111 in over 3093 trades.
The stock hit an intraday high of Rs. 5011.00 and intraday low of 4802.15. The net turnover during the day was Rs. 114671249.00. |
